EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.56 | 1,4-dihydroxy-2-naphthoic acid | - |
Homo sapiens | |
3.4.22.56 | 4-(ethoxycarbonylmethoxy)-1-hydroxy-2-naphthoic acid | CS4566, a caspase-3-specific small molecular inhibitor, binding mode, overview | Homo sapiens | |
3.4.22.56 | Ac-DNLD-CHO | from rational computational design, the inhibitor is specific due to the specific interaction of the NLD moiety with the active site of caspase-3, docking mode and site-directed mutagenesis analysis. In the active site of caspase-3, Asn in Ac-DNLDCHO specifically interacts with Ser209 in the S3 subsite, and Leu tightly interacts with the hydrophobic S2 subsite, overview | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.56 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.22.56 | commercial preparation | recombinant enzyme | Homo sapiens | - |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.22.56 | 0.0136 | - |
- |
Homo sapiens | CS4566 |